From professional translators, enterprises, web pages and freely available translation repositories.
in addition to data from bioequivalence studies, other data may need to be submitted to meet regulatory requirements for bioequivalence.
in addition to data from bioequivalence studies, other data may need to be submitted to meet regulatory requirements for bioequivalence.
Last Update: 2016-03-03
Usage Frequency: 1
Quality:
* fda cder office of generic drugs — further u.s. information on bioequivalence testing and generic drugs* birkett d (2003).
* fda cder office of generic drugs – further u.s. information on bioequivalence testing and generic drugs
Last Update: 2016-03-03
Usage Frequency: 1
Quality:
